Profil
Ryan V.
Hartwell was the founder of Conexeu Sciences, Inc., founded in 2022, where the title held was Chief Executive Officer & Director from 2022 to 2024.
Dr. Hartwell is also the founder of BirchBioMed, Inc...
Dr. Hartwell worked at Mind Cure Health, Inc. as Chief Scientific Officer and Chief Science Officer.
Dr. Hartwell completed a doctorate at the University of British Columbia and an undergraduate degree at the University of Ottawa.
Anciens postes connus de Ryan V. Hartwell
| Sociétés | Poste | Fin |
|---|---|---|
| CONEXEU SCIENCES INC. | Fondateur | 15/02/2024 |
| LNG ENERGY GROUP CORP. | Directeur Technique/Scientifique/R&D | 04/06/2021 |
| LNG ENERGY GROUP CORP. | Directeur Technique/Scientifique/R&D | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fondateur | - |
Formation de Ryan V. Hartwell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ottawa
University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mind Cure Health, Inc.
Mind Cure Health, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures, and distributes branded organic functional mushroom powder | Health Technology |
CONEXEU SCIENCES INC.
CONEXEU SCIENCES INC. BiotechnologyHealth Technology Operates as an early state medical technology company that develops and commercializes novel cellular therapies for skin restoration in wound care and aesthetics | Health Technology |
















